Impact of blood pressure and medication adherence on clinical outcomes in patients with hypertension

被引:1
作者
Kim, Hyun-Jin [1 ]
Kim, Byung Sik [1 ]
Kim, Hasung [2 ]
Lee, Jungkuk [2 ]
Shin, Jeong-Hun [1 ]
Sung, Ki-Chul [3 ]
机构
[1] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol,Guri Hosp, Guri, South Korea
[2] Hanmi Pharm Co Ltd, Data Sci Team, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea
关键词
blood pressure; adherence; medication; hypertension; cardiovascular disease; outcome; RISK; ASSOCIATION; PREVENTION; MORTALITY;
D O I
10.3389/fmed.2025.1564791
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertension is a key risk factor for cardiovascular disease. Thus, effective blood pressure (BP) management and adherence to antihypertensive medications are crucial for reducing these risks in patients with hypertension. We evaluated the effect of BP and medication adherence on the clinical outcomes of patients with hypertension. Methods: This is retrospective cohort study utilized data from the Korean National Health Insurance Database. We analyzed data from 238,950 patients with hypertension aged >= 20 who underwent at least two health checkups between 2009 and 2012. Patients were categorized according to their systolic BP (SBP) and medication adherence. The primary outcome was a composite of all-cause death, myocardial infarction, ischemic stroke, hemorrhagic stroke, and hospitalization for heart failure. Cox proportional hazard models were used to estimate hazard ratios (HR) for composite outcomes. Results: Higher SBP groups were associated with increased risk of composite outcomes compared to the 120-129 mmHg group (<120 mmHg, HR 1.065; 130-139 mmHg, HR 1.056; 140-149 mmHg, HR 1.068; and >= 150 mmHg, HR 1.238). In addition, across all SBP categories, poor adherence significantly elevated the risk of composite outcomes, even after adjusting for confounding factors. Among all categories, patients with high SBP (>= 150 mmHg) and poor adherence had the highest risk. Conclusion: Higher SBP and poor medication adherence were independently associated with worse clinical outcomes in patients with hypertension. Strategies to enhance medication adherence and achieve optimal BP control are essential to reduce cardiovascular risk.
引用
收藏
页数:12
相关论文
共 36 条
[1]   Hypertension and the J-curve phenomenon: implications for tight blood pressure control [J].
Angeli, Fabio ;
Reboldi, Gianpaolo ;
Verdecchia, Paolo .
HYPERTENSION RESEARCH, 2013, 36 (02) :109-111
[2]   Medication Adherence and Compliance: Recipe for Improving Patient Outcomes [J].
Aremu, Taiwo Opeyemi ;
Oluwole, Oluwatosin Esther ;
Adeyinka, Kehinde Oluwatosin ;
Schommer, Jon C. .
PHARMACY, 2022, 10 (05)
[3]   Fixed-dose combinations improve medication compliance: A meta-analysis [J].
Bangalore, Sripal ;
Kamalakkannan, Gayathri ;
Parkar, Sanobar ;
Messerli, Franz H. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (08) :713-719
[4]   Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials [J].
Boehm, Michael ;
Schumacher, Helmut ;
Teo, Koon K. ;
Lonn, Eva M. ;
Mahfoud, Felix ;
Mann, Johannes F. E. ;
Mancia, Giuseppe ;
Redon, Josep ;
Schmieder, Roland E. ;
Sliwa, Karen ;
Weber, Michael A. ;
Williams, Bryan ;
Yusuf, Salim .
LANCET, 2017, 389 (10085) :2226-2237
[5]   Adherence in Hypertension A Review of Prevalence, Risk Factors, Impact, and Management [J].
Burnier, Michel ;
Egan, Brent M. .
CIRCULATION RESEARCH, 2019, 124 (07) :1124-1140
[6]   Prevention and Control of Hypertension JACC Health Promotion Series [J].
Carey, Robert M. ;
Muntner, Paul ;
Bosworth, Hayden B. ;
Whelton, Paul K. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (11) :1278-1293
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association [J].
Choudhry, Niteesh K. ;
Kronish, Ian M. ;
Vongpatanasin, Wanpen ;
Ferdinand, Keith C. ;
Pavlik, Valory N. ;
Egan, Brent M. ;
Schoenthaler, Antoinette ;
Houston Miller, Nancy ;
Hyman, David J. .
HYPERTENSION, 2022, 79 (01) :E1-E14
[9]   Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020 [J].
Derington, Catherine G. G. ;
Bress, Adam P. P. ;
Herrick, Jennifer S. S. ;
Jacobs, Joshua A. A. ;
Zheutlin, Alexander R. R. ;
Berchie, Ransmond O. O. ;
Conroy, Molly B. B. ;
Cushman, William C. C. ;
King, Jordan B. B. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (11)
[10]   Hypertension and Cardiovascular Disease: Contributions of the Framingham Heart Study [J].
Franklin, Stanley S. ;
Wong, Nathan D. .
GLOBAL HEART, 2013, 8 (01) :49-57